Synonyms
Escherichia coli

How Do Bacteria Survive Antibiotics?

Some Forms of Childhood Malnutrition, Stunting May Be Preventable with Vaccines

Publish or Event Date
Research Institution
Washington University School of Medicine in St. Louis
Short Title
Some Forms of Childhood Malnutrition, Stunting May Be Preventable with Vaccines
Content Coordinator
Content Manager

Iain Fraser, Ph.D.

Specialty(s): Allergy and Immunology, Infectious Disease

Education:

Ph.D., Imperial College, University of London

Iain Fraser, Ph.D.

Michael P. O'Connell, Ph.D.

Education:

Ph.D., Cell and Molecular Biology (Developmental Origins of Health and Disease), 2006
M.Sc., Biochemical Pharmacology, 2003
B.Sc., Sport and Health Sciences, minor in Psychology, 2001

Michael O'Connell, Ph.D.

Discovering What Makes This Toxin Even Worse Than Diarrhea

Bad E. coli We Know, but Good E. coli?

Bioinformatics Resource Centers (BRCs) for Infectious Diseases

The NIAID-funded Bioinformatics Resource Centers provide data-driven, production-level, sustainable computational platforms to enable sharing and access to data, portable computational tools, and standards that support interoperability for the infectious diseases research community.

Systems Biology Consortium Resources

The Systems Biology Consortium for Infectious Diseases is a community of systems biologists who integrate experimental biology, computational tools and modeling across temporal and spatial scales to improve our understanding of infectious diseases. Through collaborative efforts, scientists test and validate hypotheses that drive innovation and discovery. The Consortium seeks to develop strategies that predict and alleviate disease severity and ultimately provide solutions to the world's most important health challenges.

Therapeutic Development Services

The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins.

This is one of several programs provided by NIAID's Division of Microbiology and Infectious Diseases to support infectious disease product developers.

Centers of Excellence for Translational Research (CETR)

In 2014, NIAID established the Centers of Excellence for Translational Research (CETR) program. Supported translational activities will range from very early discovery-based efforts to late-stage preclinical development.

The CETR program builds on work of previous NIAID-supported research and development programs, including the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) program, and is intended to complement and enhance ongoing translational and product development activities.

Main Areas of Focus

  • To advance discovery, preclinical development, production, licensure and/or use of new or improved medical countermeasures (therapeutics, immunotherapeutics, vaccines, vaccine technologies, and medical diagnostics) or related technologies for emerging and re-emerging infectious diseases

Contact Information

Awards & Locations

Each multi-project Center is organized around specific themes that address development of a targeted medical countermeasure or technology, and related regulatory barriers.

Content Coordinator
Content Manager